| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| AVR ANTERIS TECHNOLOGIES GLOBAL CORP. | SALE | 17,580 | — | — | 35,162 | Jun 7, 2026 | Jun 9, 2026 ↗ | View → |
| AVR ANTERIS TECHNOLOGIES GLOBAL CORP. | PURCHASE | 17,580 | — | — | 17,580 | Jun 7, 2026 | Jun 9, 2026 ↗ | View → |
| EVMN EVOMMUNE, INC. | SALE Chief Business & Legal Officer | 14,223 | — | — | 47,845 | May 28, 2026 | Jun 1, 2026 ↗ | View → |
| EVMN EVOMMUNE, INC. | SALE10b5-1 10b5-1 plan | 14,223 | $22.83 | $324.7K | 60,835 | May 28, 2026 | Jun 1, 2026 ↗ | View → |
| EVMN EVOMMUNE, INC. | PURCHASE Chief Business & Legal Officer | 14,223 | $1.71 | $24.3K | 75,058 | May 28, 2026 | Jun 1, 2026 ↗ | View → |
| EVMN EVOMMUNE, INC. | PURCHASEGRANT Stock grant | 115,279 | — | — | 115,279 | Apr 16, 2026 | Apr 17, 2026 ↗ | View → |
| EVMN EVOMMUNE, INC. | SALE Chief Business & Legal Officer | 13,624 | $17.84 | $243.1K | 60,835 | Dec 9, 2025 | Dec 11, 2025 ↗ | View → |
| AVR ANTERIS TECHNOLOGIES GLOBAL CORP. | PURCHASEGRANT Stock grant | 13,821 | — | — | 13,821 | Dec 3, 2025 | Dec 5, 2025 ↗ | View → |
| AVR ANTERIS TECHNOLOGIES GLOBAL CORP. | PURCHASEGRANT Stock grant | 52,742 | — | — | 52,742 | Dec 3, 2025 | Dec 5, 2025 ↗ | View → |
| EVMN EVOMMUNE, INC. | SALE Chief Business & Legal Officer | 25,000 | — | — | 0 | Nov 7, 2025 | Nov 12, 2025 ↗ | View → |
| EVMN EVOMMUNE, INC. | PURCHASE Chief Business & Legal Officer | 3,175 | — | — | 3,175 | Nov 7, 2025 | Nov 12, 2025 ↗ | View → |
| EVMN EVOMMUNE, INC. | PURCHASEGRANT Stock grant | 293,496 | — | — | 293,496 | Nov 5, 2025 | Nov 7, 2025 ↗ | View → |